Tetra Radar · Company Timeline
Ascendis Pharma A/s (ASND)
Sector: Health Care
Earlier observations
- · FDA approval. The FDA approved YUVIWEL to increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses.
Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.
Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.